State Street’s ARS Pharmaceuticals SPRY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $38.3M | Buy |
2,194,493
+163,259
| +8% | +$2.85M | ﹤0.01% | 1824 |
|
|
2025
Q1 | $25.6M | Sell |
2,031,234
-718,667
| -26% | -$9.04M | ﹤0.01% | 1987 |
|
|
2024
Q4 | $29M | Buy |
2,749,901
+700,359
| +34% | +$7.39M | ﹤0.01% | 2008 |
|
|
2024
Q3 | $29.7M | Buy |
2,049,542
+193,321
| +10% | +$2.8M | ﹤0.01% | 1983 |
|
|
2024
Q2 | $15.8M | Buy |
1,856,221
+251,671
| +16% | +$2.14M | ﹤0.01% | 2288 |
|
|
2024
Q1 | $16.4M | Buy |
1,604,550
+1,027,570
| +178% | +$10.5M | ﹤0.01% | 2290 |
|
|
2023
Q4 | $3.16M | Buy |
576,980
+40,820
| +8% | +$224K | ﹤0.01% | 3152 |
|
|
2023
Q3 | $2.03M | Buy |
536,160
+97,609
| +22% | +$369K | ﹤0.01% | 3327 |
|
|
2023
Q2 | $2.94M | Buy |
438,551
+309,360
| +239% | +$2.07M | ﹤0.01% | 3238 |
|
|
2023
Q1 | $841K | Buy |
129,191
+43,300
| +50% | +$282K | ﹤0.01% | 3593 |
|
|
2022
Q4 | $733K | Buy |
85,891
+18,300
| +27% | +$156K | ﹤0.01% | 3639 |
|
|
2022
Q3 | $357K | Hold |
67,591
| – | – | ﹤0.01% | 3902 |
|
|
2022
Q2 | $287K | Sell |
67,591
-276,603
| -80% | -$1.17M | ﹤0.01% | 4052 |
|
|
2022
Q1 | $1.21M | Buy |
344,194
+20,181
| +6% | +$70.8K | ﹤0.01% | 3746 |
|
|
2021
Q4 | $2.16M | Buy |
324,013
+18,944
| +6% | +$126K | ﹤0.01% | 3609 |
|
|
2021
Q3 | $3.05M | Buy |
305,069
+80,750
| +36% | +$806K | ﹤0.01% | 3489 |
|
|
2021
Q2 | $6.93M | Buy |
224,319
+32,155
| +17% | +$993K | ﹤0.01% | 3089 |
|
|
2021
Q1 | $8.38M | Buy |
+192,164
| New | +$8.38M | ﹤0.01% | 2825 |
|